4//SEC Filing
Rafferty Emily Ann 4
Accession 0001628908-25-000032
CIK 0001628908other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 9:02 PM ET
Size
10.3 KB
Accession
0001628908-25-000032
Insider Transaction Report
Form 4
Rafferty Emily Ann
Chief Operating Officer
Transactions
- Tax Payment
Class A Common Stock
2025-03-01$8.99/sh−9,274$83,373→ 54,134 total - Award
Class A Common Stock
2025-03-03+72,937→ 127,071 total - Award
Class A Common Stock
2025-03-03+5,490→ 132,561 total - Tax Payment
Class A Common Stock
2025-03-03$8.77/sh−2,433$21,337→ 130,128 total
Footnotes (6)
- [F1]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units.
- [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F3]Represents restricted stock units granted to Ms. Rafferty pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- [F4]Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028.
- [F5]Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024.
- [F6]This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units.
Documents
Issuer
Evolent Health, Inc.
CIK 0001628908
Entity typeother
Related Parties
1- filerCIK 0001983577
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 9:02 PM ET
- Size
- 10.3 KB